These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10077288)
1. Will the novel antipsychotics significantly ameliorate neuropsychological deficits and improve adaptive functioning in schizophrenia? Hawkins KA; Mohamed S; Woods SW Psychol Med; 1999 Jan; 29(1):1-8. PubMed ID: 10077288 [No Abstract] [Full Text] [Related]
2. [The use of atypical antipsychotics in the long-term care of schizophrenia]. Limosin F Encephale; 2006 Dec; 32 Pt 3():S1065-71. PubMed ID: 17356501 [No Abstract] [Full Text] [Related]
4. Use of novel antipsychotic drugs. Raleigh F Pharmacotherapy; 1996; 16(6 Pt 2):160S-165S; discussion 166S-168S. PubMed ID: 8948000 [TBL] [Abstract][Full Text] [Related]
5. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167 [TBL] [Abstract][Full Text] [Related]
6. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO]. István S; Agoston T; Tamás T; Zoltán J Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029 [TBL] [Abstract][Full Text] [Related]
7. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations. J Clin Psychiatry; 1998; 59 Suppl 12():35-40. PubMed ID: 9766618 [TBL] [Abstract][Full Text] [Related]
9. All antipsychotics are equal, but some are more equal than others. Volavka J; Citrome L J Clin Psychiatry; 2009 Mar; 70(3):429-30. PubMed ID: 19317959 [No Abstract] [Full Text] [Related]
10. Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications. Savina I; Beninger RJ Schizophr Res; 2007 Aug; 94(1-3):128-38. PubMed ID: 17560766 [TBL] [Abstract][Full Text] [Related]
11. Management of treatment-resistant patients with schizophrenia. Marder SR J Clin Psychiatry; 1996; 57 Suppl 11():26-30. PubMed ID: 8941168 [TBL] [Abstract][Full Text] [Related]
12. Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics. Strejilevich SA; Palatnik A; Avila R; Bustin J; Cassone J; Figueroa S; Gimenez M; de Erausquin GA Psychiatry Res; 2005 Feb; 133(2-3):277-80. PubMed ID: 15741003 [TBL] [Abstract][Full Text] [Related]
14. Risperidone response after no clozapine response. Avnon M; Kunin A Br J Psychiatry; 1995 Nov; 167(5):699. PubMed ID: 8564340 [No Abstract] [Full Text] [Related]
15. Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients. Franz M; Lis S; Plüddemann K; Gallhofer B Br J Psychiatry; 1997 May; 170():422-5. PubMed ID: 9307690 [TBL] [Abstract][Full Text] [Related]
16. Cognitive differences in schizophrenia on long-term treatments with clozapine, risperidone and typical antipsychotics. Han M; Zhang XY; Chen DC; Tan YL; Song CS; Yu YH; Huang XF Int Clin Psychopharmacol; 2015 Mar; 30(2):89-95. PubMed ID: 25568968 [TBL] [Abstract][Full Text] [Related]
17. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group. Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652 [No Abstract] [Full Text] [Related]
18. Clozapine alone versus clozapine and risperidone with refractory schizophrenia. Honer WG; Thornton AE; Chen EY; Chan RC; Wong JO; Bergmann A; Falkai P; Pomarol-Clotet E; McKenna PJ; Stip E; Williams R; MacEwan GW; Wasan K; Procyshyn R; N Engl J Med; 2006 Feb; 354(5):472-82. PubMed ID: 16452559 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. Zink M; Kuwilsky A; Krumm B; Dressing H J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423 [TBL] [Abstract][Full Text] [Related]
20. Are second generation antipsychotics a distinct class? Bonham C; Abbott C J Psychiatr Pract; 2008 Jul; 14(4):225-31. PubMed ID: 18664891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]